YBR138C Antibody

What is YBR238C and what cellular functions is it associated with?

YBR238C, also named AAG1 (Aging-Associated Gene 1), is an uncharacterized yeast gene that functions as an effector of TORC1. It regulates chronological lifespan through mitochondrial-dependent pathways, negatively impacting mitochondrial function largely via HAP4- and RMD9-dependent mechanisms. The gene is downregulated by rapamycin, and its deletion increases both chronological lifespan (CLS) and replicative lifespan (RLS) .

How do I select the appropriate antibody for detecting YBR238C in my research?

When selecting antibodies for yeast proteins like YBR238C, leverage resources such as YCharOS, which provides comprehensive knockout characterization data for antibodies. YCharOS evaluates antibodies using techniques such as Western blot, immunoprecipitation, and immunofluorescence. For optimal selection, review performance data across multiple techniques and prioritize antibodies validated with proper controls, especially those tested in knockout models to confirm specificity .

What positive and negative controls should I include when working with YBR238C antibodies?

For rigorous experimental design, include wild-type yeast strains (BY4743 and CEN.PK backgrounds have been documented) as positive controls and ybr238c∆ knockout strains as negative controls to confirm antibody specificity. Additionally, incorporate appropriate loading controls for Western blots and secondary antibody-only controls to identify any non-specific binding .

How can I use YBR238C antibodies to study its interaction with the TORC1 pathway?

To investigate interactions between YBR238C and the TORC1 pathway, employ co-immunoprecipitation with antibodies against YBR238C and TORC1 components. Research indicates that YBR238C is downregulated by rapamycin (a TORC1 inhibitor) and functions as an effector of TORC1. Immunoprecipitation followed by mass spectrometry can help identify protein complexes. Additionally, use antibodies in combination with rapamycin treatment to analyze changes in YBR238C expression, localization, or post-translational modifications .

What methodologies can I implement to investigate YBR238C's role in mitochondrial function?

To examine YBR238C's mitochondrial function, employ multiple complementary approaches:

• Immunofluorescence microscopy to co-localize YBR238C with mitochondrial markers

• Chromatin immunoprecipitation (ChIP) to study if YBR238C interacts with mitochondrial DNA

• Proximity ligation assays to detect interactions with other mitochondrial proteins

• Western blots comparing YBR238C levels under different respiratory conditions

• RNA immunoprecipitation (RIP) to identify RNA targets, given that YBR238C has a pentatricopeptide repeat region suggesting RNA binding capacity

How can I investigate the antagonistic relationship between YBR238C and its paralog RMD9?

Based on current research, YBR238C and RMD9 have opposite effects on mitochondrial function and cellular aging. To investigate this relationship systematically:

• Use antibodies against both proteins to compare expression patterns and localization

• Perform co-immunoprecipitation to test for direct interaction

• Analyze protein levels in single and double deletion mutants

• Conduct RNA-binding studies to identify common or distinct RNA targets

• Compare phenotypic outcomes in single vs. double mutants to establish genetic interactions

What are the best practices for designing flow cytometry experiments using YBR238C antibodies?

For flow cytometry studies involving yeast proteins like YBR238C, implement these methodological considerations:

• Sample preparation: Create proper single-cell suspensions, considering cell concentration and storage temperature to maintain viability

• Panel design: Use flow panel builder tools to select compatible fluorophores based on your instrument's lasers and filters

• Controls: Include single-stain controls for compensation, FMO (fluorescence minus one) controls, and knockout strains as negative controls

• Analysis: Develop gating strategies that allow identification of relevant populations based on marker expression

How do I optimize Western blot protocols for detecting YBR238C?

For optimal Western blot detection of YBR238C:

• Use efficient yeast cell lysis methods compatible with mitochondrial proteins

• Consider appropriate buffer systems that maintain protein integrity

• Test different membrane types (PVDF vs. nitrocellulose)

• Determine optimal primary antibody concentrations through titration experiments

• Include proper loading controls and negative controls (ybr238c∆ strains)

• For mitochondrial proteins, consider enrichment through subcellular fractionation prior to Western blot analysis

What considerations are important when using YBR238C antibodies for immunofluorescence in yeast cells?

For successful immunofluorescence with YBR238C:

• Optimize cell wall digestion to improve antibody accessibility while maintaining cell morphology

• Consider fixation methods compatible with mitochondrial proteins

• Use appropriate permeabilization conditions

• Co-stain with mitochondrial markers to confirm localization

• Include knockout strains as negative controls to confirm specificity

• Use confocal microscopy for accurate determination of mitochondrial co-localization

How do I interpret transcriptional changes related to YBR238C function?

Research shows that YBR238C deletion causes upregulation of 326 genes and downregulation of 61 genes. To properly interpret these changes:

• Focus on the significantly altered pathways, particularly mitochondrial respiratory genes

• Compare your transcriptome data with published datasets (e.g., YBR238C deletion upregulates HAP4 and mitochondrial electron transport chain genes)

• Use gene set enrichment analysis to identify overrepresented pathways

• Correlate transcriptional changes with phenotypic outcomes like ATP levels, ROS production, and lifespan alterations

• Validate key findings with RT-qPCR for specific genes of interest

How can I quantitatively assess mitochondrial function changes in YBR238C experiments?

Based on published research, quantitative assessment should include:

• ATP measurements to evaluate energy production (increased in ybr238c∆ mutants)

• ROS level determination to assess oxidative stress (decreased in ybr238c∆ mutants)

• Growth measurements on respiratory media to evaluate respiratory capacity

• Expression analysis of ETC complex genes (I-V) via qRT-PCR

• Mitochondrial membrane potential measurements using appropriate fluorescent dyes

The following table summarizes key findings that can serve as benchmarks for your experiments :

How do I resolve conflicting antibody results in YBR238C research?

When facing conflicting results:

• Consider the inherent strengths and limitations of each technique

• Review antibody validation data to assess specificity in different applications

• Evaluate the possibility of post-translational modifications affecting antibody recognition

• Confirm results with orthogonal methods not reliant on antibodies

• Use genetic approaches (e.g., epitope tagging) to resolve conflicts

What are common issues when working with antibodies against yeast proteins like YBR238C?

Common challenges include:

• Non-specific binding: Optimize blocking conditions, antibody concentrations, and washing steps

• Low signal: Consider more sensitive detection methods, increased protein loading, or alternative antibodies

• Background in immunofluorescence: Improve washing steps, optimize fixation and permeabilization

• Inconsistent results between experiments: Standardize protocols, use the same antibody lot

• Cell wall interference: Optimize spheroplasting or cell wall digestion protocols

How can I integrate YBR238C antibody studies with genetic approaches?

For comprehensive analysis:

• Compare protein expression in wild-type vs. mutant strains (ybr238c∆, hap4∆, rmd9∆, and double mutants)

• Create epitope-tagged versions of YBR238C for antibody detection when native antibodies are unavailable

• Use antibodies to detect protein changes in genetic suppressor screens

• Correlate antibody-based protein detection with phenotypic assays (lifespan, mitochondrial function)

What bioinformatic approaches can complement YBR238C antibody studies?

Integrate these computational approaches:

• Protein sequence analysis to investigate the pentatricopeptide repeat region (residues 130-675) and intrinsically unstructured region (first ~130 residues)

• Comparative genomics to identify conserved features across species

• Pathway analysis to place YBR238C in the context of TORC1–Mitochondria–TORC1 (TOMITO) signaling

• Prediction of RNA binding sites based on structural features

• Molecular modeling to understand functional implications of protein structure

What are the key structural and functional properties of YBR238C?

YBR238C is a 731 amino acid protein with these key features:

• Intrinsically unstructured region over the first ~130 residues

• Pentatricopeptide repeat region (residues 130-675)

• Mitochondrial localization

• Downregulation by rapamycin (TORC1 inhibitor)

• Negative regulation of mitochondrial function

• Predicted RNA binding function (similar to paralog RMD9)

• Part of the TORC1–Mitochondria–TORC1 (TOMITO) signaling process

How does YBR238C relate to aging and TORC1 signaling?

YBR238C represents a critical link between TORC1 signaling and aging:

• Deletion increases both chronological lifespan (CLS) and replicative lifespan (RLS)

• It is downregulated by rapamycin treatment

• Functions as an effector of TORC1

• Negatively regulates HAP4, a transcription factor that controls mitochondrial respiration

• Forms part of a feedback loop between TORC1 and mitochondria that regulates cellular aging

• Deletion enhances mitochondrial function, while overexpression accelerates aging via mitochondrial dysfunction